Market Research Assistance

On the Web
Refine Result

By Date

Last Month
Last 3 Months
Last 6 Months
Last Year
Last 2 Years

By Price

< $1000
$1000-$2500
$2501-$4000
$4001-$5500
$5501-$7500
$7501-$9000
>$9000

Pulmonary therapeutics Market Research Reports

Titlepublishedprice

Chronic Obstructive Pulmonary Disease - Pipeline Review, H1 2017

By Global Markets Direct
"...... a group of lung diseases. It is characterized by inability to completely breathe out air from the lungs leading to shortness of breath. The airflow to the lungs is further blocked. Other symptoms include cough, fatigue and chest pain. The disease te......"
16-May-2017$2000

Idiopathic Pulmonary Fibrosis - Pipeline Review, H1 2017

By Global Markets Direct
"...... disease characterized by inflammation and scarring of lung tissue and loss of lung function. Symptoms of IPF include dry cough, shortness of breath, especially during or after physical activity, lasting tiredness and weight loss. Risk factors include......"
16-May-2017$2000

United States Idiopathic Pulmonary Fibrosis Drug Market Report 2017

By QYResearch Group
"...... seven regions: - The West - Southwest - The Middle Atlantic - New England - The South - The Midwest with sales (volume), revenue (value), market share and growth rate of Idiopathic Pulmonary Fibrosis ......"
26-Apr-2017$3800

Global Pneumonia Partnering 2010-2017

By Current Partnering
"...... rt provides understanding and access to partnering deals and agreements entered into by the world's leading healthcare companies. • Trends in partnering deals • Top deals by value • Deals listed by company A-Z, industry s......"
01-Apr-2017$1495

Global COPD Partnering 2010 to 2017

By Current Partnering
"...... s understanding and access to partnering deals and agreements entered into by the world's leading healthcare companies. • Trends in partnering deals • Top deals by value • Deals listed by company A-Z, industry sector, sta......"
01-Apr-2017$1495

Global Idiopathic Pulmonary Fibrosis Partnering 2010 to 2017

By Current Partnering
"...... ing Terms and Agreements since 2010 report provides understanding and access to partnering deals and agreements entered into by the world's leading healthcare companies. • Trends in partnering deals • Top deals by value •......"
01-Apr-2017$1495

Pulmonary Embolism - Pipeline Review, H1 2017

By Global Markets Direct
"...... br /> Pulmonary embolism is the sudden blockage of a major blood vessel (artery) in the lung, usually by a blood clot. Symptoms include shortness of breath, chest pain, cough, leg pain or swelling, excessive sweating, rapid or irregular heartb......"
15-Mar-2017$2000

Pulmonary Arterial Hypertension - Pipeline Review, H1 2017

By Global Markets Direct
"...... blood pressure that occurs in the right side of the heart and in the arteries that supply blood to the lungs. Symptoms include chest pain, fatigue, passing out suddenly, and swelling of the legs (edema). Risk factors include family history, age, obes......"
08-Mar-2017$2000

Idiopathic Pulmonary Fibrosis-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2017

By Delve Insight
"...... ic Pulmonary Fibrosis Report is to understand the market and pipeline status of the drugs around the Idiopathic Pulmonary Fibrosis to explore the generic development opportunities, licensing opportunities and to gain competitive advantage on designin......"
01-Jan-2017$2000

Idiopathic Pulmonary Fibrosis-Pipeline Insights, 2017

By Delve Insight
"...... g Discovery, Pre-clinical, IND, Phase I, Phase II, Phase III and Preregistration. Report covers the product clinical trials information and other development activities including technology, licensing, collaborations, acquisitions, fundings, patent a......"
01-Jan-2017$1250

Avail upto 25% Discount on below Publisher Reports.